Société Longboard Pharmaceuticals, Inc.
Actions
LBPH
US54300N1037
Recherche biotechnologique et médicale
Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
20,48 USD | -3,10 % | -6,96 % | +239,30 % |
Métier
Nombre d'employés: 50
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Kevin Lind
CEO | Chief Executive Officer | 47 | 03/01/20 |
Brandi Roberts
DFI | Director of Finance/CFO | 50 | 01/01/21 |
Chief Tech/Sci/R&D Officer | - | - | |
Dewey McLin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Randall Kaye
CTO | Chief Tech/Sci/R&D Officer | 61 | 21/03/22 |
Julie Baker
PRN | Corporate Officer/Principal | - | 01/01/23 |
Gus Cardenas
PRN | Corporate Officer/Principal | - | - |
Anne Danks
PRN | Corporate Officer/Principal | - | - |
Marco Peters
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 65 | 01/12/20 |
Director/Board Member | 67 | 01/12/20 | |
Vincent Aurentz
BRD | Director/Board Member | 56 | 01/02/20 |
Casey Lynch
BRD | Director/Board Member | 50 | 01/02/21 |
Kevin Lind
CEO | Chief Executive Officer | 47 | 03/01/20 |
Corinne Le Goff
BRD | Director/Board Member | 58 | 01/03/21 |
Jane Tiller
BRD | Director/Board Member | 64 | 15/11/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 5 270 755 | 0 | 0 | 85,50 % |
Action B | 1 | 33 609 299 | 33 242 929 ( 98,91 %) | 0 |
Coordonnées société
Longboard Pharmaceuticals, Inc.
4275 Executive Square Suite 950
92037, La Jolla
+
http://www.longboardpharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+239,30 % | 822 M | |
+7,61 % | 113 Md | |
+10,56 % | 106 Md | |
+0,41 % | 22,27 Md | |
-12,17 % | 22,22 Md | |
-5,99 % | 19,43 Md | |
-37,36 % | 17,87 Md | |
-5,10 % | 17,24 Md | |
+6,70 % | 14,29 Md | |
+35,87 % | 12,52 Md |
- Bourse
- Actions
- Action LBPH
- Société Longboard Pharmaceuticals, Inc.